DAVID
BEARSS PH.D.
HALIA THERAPEUTICS, FOUNDER & CEO
WHAT DO YOU DO?
Dr. David J. Bearss is an experienced entrepreneur and drug developer with more than 20 years experience in drug discovery. He is an expert in small molecule drug development and in the use of genetic model systems and computational techniques applied to drug discovery Dave has discovered 16 compounds that have moved forward in clinical development and has been a founder of eight biotech companies.
WHAT DOES YOUR COMPANY DO?
At Halia Therapeutics, we are discovering and developing novel therapies to improve the lives of patients with inflammatory disorders and neurological diseases. We do this by advancing innovative medicines that target the immune system’s response to resolve chronic inflammation and eliminate the damage caused by aberrantly activated immune responses.